Krishana Phoschem Ltd

- No specific new fundraising through debt or equity has been declared or announced as of now. - The company mentions working on various projects and expansions but states that any capital expenditure (CAPEX) plans will be communicated only after regulatory approvals. - They emphasize declaring CAPEX at appropriate times with a proper debt-equity ratio to support expansion. - The management highlights having very good cash flow and maintaining financial strength (supported by CRISIL A+ Stable credit rating). - No additional capital raises are planned in the near term; current focus is on utilizing existing capacity expansions and managing working capital efficiently. - Investor updates regarding any future expansions or fundraising will be provided when finalized and approved by regulators.

- The Company has recently completed a significant capacity expansion: NPK/DAP capacity increased by 50% to 495,000 MTPA, SSP capacity at 120,000 MTPA, totaling 615,000 MTPA phosphatic fertilizer capacity. - Backward integration strengthened with sulphuric acid capacity of 99,000 MTPA. - Green Ammonia Sale Agreement (GASA) for 70,000 MTPA under the National Green Hydrogen Mission, with green ammonia expected to start supply after approximately three years. - No additional capex or expansion plans have been declared beyond the current expansion. - Management indicated that they keep planning business expansions and will update investors after regulatory declarations. - FY27 capex estimates are not disclosed yet due to pending statutory approvals. - The company maintains a disciplined capital allocation funded through internal accruals and term loans. - Overall, future capex is under evaluation, with new projects being worked on but no firm announcements yet.

- FY27 revenue growth expected at 35%-40%, driven by capacity utilization and imports. - Top-line increase of around Rs. 500 crore anticipated from a 50% increase in NPK/DAP capacity (approx. 80,000 tons increase × Rs. 60,000 per ton). - Manufacturing volumes for FY26 were approx. 383,000 MT and trading volumes approx. 93,000 MT; growth expected with stable or increased volumes in FY27. - Capacity expansion commenced in April FY27; full utilization expected after initial quarter. - Trading sales are expected to continue to complement manufacturing with around Rs.1,000 crore in imports projected for FY27. - Margins may face some pressure due to rising input costs but profitability to be sustained through price adjustments and government subsidies. - The company remains committed to maintaining performance and achieving growth with improved scale and operating leverage.

- FY27 revenue growth expected at 35%-40%, led by capacity expansion and increased manufacturing plus imports. - Topline increase of ~Rs.500 crore projected from 165,000 tons capacity addition, reaching Rs.2,900-3,000 crore revenue range. - EBITDA margins may face pressure in FY27 due to higher input costs (e.g., sulfur), but the company aims to sustain reasonable profitability through a mix of government subsidies and MRP price adjustments. - Management is committed to maintaining profitability; however, Q1 FY27 may have margin moderation with expected stabilization in later quarters. - EPS growth momentum is anticipated to continue consistent with revenue and profit growth, supported by operational efficiencies and financial management. - Long-term growth supported by integration initiatives and sustainability projects like Green Ammonia, enhancing value creation. - No definitive CAPEX plans declared for FY27 as company awaits regulatory approval, focusing on efficient utilization of current capacity.

- The transcript does not explicitly mention the current or expected order book or pending orders for Krishna Phoschem Limited. - The discussion focuses on capacity utilization, expansion, and expected revenues but does not specify order backlog details. - Management emphasizes strong production volumes and healthy channel inventory, indicating stable demand. - They highlight completed capacity expansion and ongoing efforts for future projects, but no specific backlog figures are given. - Cash flow and receivables related queries suggest demand is being met without bottlenecks. - Overall, no quantifiable order book or pending orders data is provided in the Q4 FY26 earnings call transcript.